Key result
The multi-disciplinary Risk Assessment and Management Programme for Hypertension (RAMP-HT) evaluation protocol outlines the methodology for assessing the quality of care and effectiveness of the programme, with no clinical results yet available.
Why the study?
Does a multi-disciplinary Risk Assessment and Management Programme for Hypertension (RAMP-HT) improve blood pressure, LDL-C, and estimated 10-year CVD risk in hypertensive patients without diabetes?
Does a multi-disciplinary Risk Assessment and Management Programme for Hypertension (RAMP-HT) improve blood pressure, LDL-C, and estimated 10-year CVD risk in hypertensive patients without diabetes?
This study protocol outlines the evaluation of a multi-disciplinary risk assessment and management program for hypertension in Hong Kong primary care to determine its effectiveness in improving clinical outcomes and reducing cardiovascular risk.
RAMP-HT effectiveness in hypertension remains unproven; leaves open whether multi-disciplinary programs improve outcomes pending completed evaluation.
BACKGROUND: There is some evidence to support a risk-stratified, multi-disciplinary approach to manage patients with hypertension in primary care. The aim of this study is to evaluate the quality of care (QOC) of a multi-disciplinary Risk Assessment and Management Programme for Hypertension (RAMP-HT) for hypertensive patients in busy government-funded primary care clinics in Hong Kong. The objectives are to develop an evidence-based, structured and comprehensive evaluation framework on quality of care, to enhance the QOC of the RAMP-HT through an audit spiral of two evaluation cycles and to determine the effectiveness of the programme in reducing cardiovascular disease (CVD) risk. METHOD/DESIGN: A longitudinal study is conducted using the Action Learning and Audit Spiral methodologies to measure whether pre-set target standards of care intended by the RAMP-HT are achieved. A structured evaluation framework on the quality of structure, process and outcomes of care has been developed based on the programme objectives and literature review in collaboration with the programme workgroup and health service providers. Each participating clinic is invited to complete a structure of care evaluation questionnaire in each evaluation cycle. The data of all patients who have enrolled into the RAMP-HT in the pre-defined evaluation periods are used for the evaluation of the process and outcomes of care in each evaluation cycle. For evaluation of the effectiveness of RAMP-HT, the primary outcomes including blood pressure (both systolic and diastolic), low-density lipoprotein cholesterol and estimated 10-year CVD risk of RAMP-HT participants are compared to those of hypertensive patients in usual care without RAMP-HT. DISCUSSION: The QOC and effectiveness of the RAMP-HT in improving clinical and patient-reported outcomes for patients with hypertension in normal primary care will be determined. Possible areas for quality enhancement and standards of good practice will be established to inform service planning and policy decision making.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2015) studied Hypertension (n=2,496). Risk Assessment and Management Programme for Hypertension (RAMP-HT) vs. Usual care was evaluated on Proportion of clinics satisfying structure of care criteria, proportion of patients achieving BP < 140/90 mmHg, and HT-related complication rates. The multi-disciplinary Risk Assessment and Management Programme for Hypertension (RAMP-HT) evaluation protocol outlines the methodology for assessing the quality of care and effectiveness of the programme, with no clinical results yet available.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: